https://www.selleckchem.com/pr....oducts/CHR-2797(Tose
01). The XX null genotype showed a higher risk for LV dilation (hazard ratio 9.04). This study revealed that the ACTN3 XX null genotype was associated with a lower left ventricular dilation-free survival rate in patients with DMD. These results suggest that the ACTN3 genotype should be determined at the time of diagnosis of DMD to improve patients' cardiac outcomes. This study revealed that the ACTN3 XX null genotype was associated with a lower left ventricular dilation-free survival rate in patients with DMD. These results
Like
Comment
Share
